Consistent with previous findings, BCL7A expression in the BCL7 family was solely an independent prognostic indicator of the survival of GBM patients both in TCGA and CGGA datasets (Tables 3 and 4, respectively). This evidence concerns the gene BCL7A and glioblastoma.